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Original Article
Evaluation of Hybrid Arc and Volumetric-
Modulated Arc Therapy Treatment Plans
for Fractionated Stereotactic
Intracranial Radiotherapy
Jun Li, PhD1 , David To, MS1, Vickie Gunn1, Wenyin Shi, MD, PhD1,
Yan Yu, PhD1, and Haisong Liu, PhD1
Abstract
Purpose: The study was aimed to compare hybrid arc and volumetric-modulated arc therapy treatment plans for fractionated
stereotactic radiotherapy of brain tumors. Methods: Treatment plans of 22 patients were studied. Hybrid arc and volumetric-
modulated arc therapy plans were generated using Brainlab iPlanDose and Varian Eclipse treatment planning systems, respec-
tively, with 6 MV photon beams on a Varian TrueBeam STx linear accelerator (Palo Alto, CA). Prescription dose was 54 Gy. The
fractionation was 1.8 Gy per fraction and 30 fractions in total, or 2 Gy per fraction and 27 fractions in total. Planning target volume
ranged from 2.4 to 28.6 cm3. Dose conformity index, gradient index, homogeneity index, and maximum doses in organs at risk
were compared. Wilcoxon signed rank test was used to determine statistical significance in paired comparison. Results: Con-
formity indexes of hybrid arc and volumetric-modulated arc therapy plans are 1.10+ 0.10 and 1.14+ 0.07, respectively (P ¼ .4);
gradient indexes are 5.02+ 1.20 and 5.64+ 1.28, respectively (P¼ .0001); homogeneity indexes are 1.02+ 0.01 and 1.05+ 0.01,
respectively (P ¼ .0001); brainstem maximum doses are 53.87 + 1.63 Gy and 54.06 + 3.17 Gy, respectively (P ¼ .1); and optic
chiasm maximum doses are 53.86+ 1.28 Gy and 53.95+ 1.81, respectively (P¼ .4). The monitor unit efficiencies of hybrid arc and
volumetric-modulated arc therapy plans are 2.57+ 0.25 MU/cGy and 2.68+ 0.24 MU/cGy, respectively (P¼ .2). The differences of
conformity index, gradient index, and homogeneity index between hybrid arc and volumetric-modulated arc therapy plans are small:
0.08+ 0.05, 0.65+ 0.46, and 0.02+ 0.01, respectively. The maximum doses in organs at risks are similar between hybrid arc and
volumetric-modulated arc therapy plans. Hybrid arc and volumetric-modulated arc therapy plans, which have similar monitor unit
efficiencies, present similar dosimetric results in the fractionated intracranial radiotherapy.
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Abbreviations
CI, conformity index; DCA, dynamic conformal arc; FSRT, fractionated stereotactic radiotherapy; GI, gradient index; HA, hybrid
arc; HI, homogeneity index; IMRT, intensity-modulated radiation therapy; MU, monitor unit; MLC, multi-leaf collimator; OAR,
organs at risk; PTV, planning target volume; QA, quality assurance; TPS, treatment planning system; VMAT, volumetric-modulated
arc therapy.
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Introduction
Two inverse-planning-based treatment techniques, intensity-
modulated radiation therapy (IMRT) and volumetric-
modulated arc therapy (VMAT), are popularly used in radiation
therapy.1-3 In IMRT, treatment beams are delivered at fixed
linear accelerator gantry angles and beam intensity is
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modulated with multi-leaf collimator (MLC) to generate opti-
mized dose distribution. In VMAT, treatment beams are deliv-
ered when machine gantry is rotating and beam intensity is
modulated with MLC at the same time to generate optimized
dose distribution. Because of inverse planning, compared to
regular forward-planning-based treatments, IMRT and VMAT
can provide better dose conformity on target and can limit
doses on organ at risk (OAR). There have been many studies
on comparison of these 2 techniques.4-8 Hybrid arc (HA) is a
hybrid technique which combines dynamic conformal arc
(DCA; ie, beam is delivered when linear accelerator gantry is
rotating in an arc and beam aperture is changed to conform to
planning target volume [PTV]) with IMRT beams at fixed
gantry angles. A study showed that HA is a good option for
treating esophageal cancer with thoracic involvement.9 A study
of cranial tumor treatment and prostate treatment showed that
compared to DCA and IMRT, HA improved dose confor-
mity.10 A study of rectal cancer treatment showed that com-
pared to VMAT, HA achieved similar target coverage but was
less efficient in sparing small bowel and bladder.11
We have been using HA routinely at our institution for
fractionated stereotactic radiotherapy (FSRT) of brain tumors.
It is of interest to compare the quality of HA and VMAT
intracranial treatment plans. To the authors’ knowledge, there
is no such publication. In this article, we conducted a retro-
spective dosimetric study to evaluate HA and VMAT for intra-
cranial radiotherapy.
Material and Method
Patient
Twenty-two brain patients treated with FSRT at our institution
under an institutional-review-board approved study were
included. The patients were treated on a Varian TrueBeam STx
linear accelerator (Palo Alto, California) using 6 MV photon
beams, with HA or VMAT plans. The linear accelerator is
equipped with high-definition MLC HD120 (central 8 cm of
2.5 mm thick leaf and outer 14 cm of 5 mm thick leaf). The
patients had skull-based benign tumors. Total treatment dose
was 54 Gy. The fractionation was 1.8 Gy per fraction and 30
fractions in total, or 2 Gy per fraction and 27 fractions in total.
Planning target volume ranged from 2.4 to 28.6 cm3. Table 1
lists the patients’ tumor locations and PTV sizes.
Treatment Plan
In the study, 2 plans (HA and VMAT plans) were generated for
each patient. Hybrid arc plans were generated using Brainlab
iPlanDose treatment planning system (TPS; version 4.5.4). The
HA plans included 3 to 4 noncoplanar dynamic arcs and 5 to 6
IMRT beams which were located at the beginning or the end of
a dynamic arc. The ratio of the weights of dynamic arcs and
IMRT beams was chosen based on the idea: to have the
dynamic arcs provide most of the dose which is spread out to
minimize the entrance dose to reduce hair loss; while to allow
the IMRT beams to have enough room to provide modulation
for the final plan optimization. Based on our clinical experi-
ence, we found the ratio 8:2 or 7:3 led to better planning results,
compared to other ratios. Volumetric-modulated arc therapy
treatment plans were generated using a Varian Eclipse TPS
(Version 11.0) with 3 to 4 noncoplanar VMAT arcs, which
were in the same geometry as the dynamic arcs in HA plans.
Planning computed tomography image slice thickness was
1.25 mm. Density correction was applied and a grid size of
1 mm was used in both HA and VMAT plan dose calculations.
Dose constraints for OAR, for example, 60 Gy for brainstem
maximum dose and 56 Gy for optic chiasm maximum dose,
were applied in the inverse planning.
BrainLAB iPlanDose TPS provides 4 different options for
IMRT portion of the plan. We selected the “PTV only” option,
which usually generates a more homogeneous dose distribution
than using other options. In VMAT planning, a tuner structure
was generated by expanding the PTV with 3 mm uniform out-
side margin and was used in the optimization to help achieve
homogenous dose distribution within the PTV. Planning target
volume was generally set to have a lower dose objective to
have 100% volume covered by the prescription dose; while the
tuner structure was set to have a maximum dose objective no
greater than 102% of the prescription dose, and it was given the
same level of priority.
For comparison, both HA and VMAT plans were normal-
ized to make prescription dose cover 95% of PTV. Dose con-
formity index (CI; ratio of prescription isodose volume to
PTV), gradient index (GI; ratio of 50% prescription isodose
Table 1. Tumor Location and PTV Size of the 22 Patients.
Patient Tumor Location PTV (cm3)
1 Left optic nerve 5.5
2 Right brain/neck region 20.2
3 Left cerebellopontine angle 3.3
4 Right cerebellopontine angle 8.5
5 Sellar region 16.6
6 Right cavernous sinus 28.6
7 Right occipital 24.2
8 Olfactory groove 7.2
9 Brainstem/thalamus region 23.3
10 Left cerebellopontine angle 11.9
11 Right temporal 18.0
12 Right base of skull 20.4
13 Right cerebellopontine angle 22.8
14 Left optic nerve 2.4
15 Right planum sphenoidale 5.7
16 Planum sphenoidale and paranasal sinuses 15.6
17 Right cavernous sinus 24.6
18 Right cerebellopontine angle 13.7
19 Left cavernous sinus 10.3
20 Left cavernous sinus 6.1
21 Right cavernous sinus 14.4
22 Right cavernous sinus 21.3
Abbreviation: PTV, Planning target volume.
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volume to PTV), and homogeneity index (HI; ratio of maximum
dose in PTV to prescription dose) were compared between HA
and VMAT plans of the 22 patients. The OAR doses in some
patients were insignificant because the OARs were located far
away from the tumors. In the comparison of brainstem maxi-
mum doses, only those patients whose brainstem maximum
doses were close to or larger than 50 Gy were included. These
patients’ results may better reflect the capability of treatment
planning optimization of the planning systems because the OAR
doses were closer to the OAR constraints. Similarly, in compar-
ison of optic chiasm maximum doses, only those patients whose
optic chiasm maximum doses were close to or larger than 50 Gy
were included. Fifteen patients’ brainstem maximum doses from
HA and VMAT plans were compared, and 13 patients’ optic
chiasm maximum doses were compared. Monitor unit (MU)
efficiencies, that is, MU/prescription dose, of HA and VMAT
plans, were also compared. Wilcoxon signed rank test was used
to determine statistical significance in paired comparison with P
value threshold of .05.
Results
Figure 1 shows dose distributions of HA and VMAT plans of a
patient. The 100% prescription isodose line (5400 cGy) and
50% prescription isodose line (2700 cGy) are shown. In this
case, 4 DCAs and 6 IMRT beams were used in the HA plan,
and 4 VMAT arcs were used in the VMAT plan. The isodose
distributions look similar in the 2 plans.
Figures 2 to 4 show CI, GI, and HI of HA and VMAT plans
of the 22 patients, respectively. Conformity indexs of HA and
VMAT plans are 1.10 + 0.10 (range: 0.94-1.25) and 1.14 +
0.07 (range: 1.03-1.27), respectively; GIs are 5.02 + 1.20
(range: 3.47-8.11) and 5.64+ 1.28 (range: 3.57-8.55), respec-
tively; HIs are 1.02+ 0.01 (range: 1.01-1.05) and 1.05+ 0.01
(range: 1.03-1.08), respectively. Figure 5 shows brainstem
maximum doses of the 15 patients. Brainstem maximum doses
in HA and VMAT plans are 53.87 + 1.63 Gy (range: 49.62-
55.14 Gy) and 54.06 + 3.17 Gy (range: 44.77-56.69 Gy),
respectively. Figure 6 shows optic chiasm maximum doses of
Figure 1. Dose distributions of HA plan (left side) and VMAT plan (right side) of a patient. Planning target volume (PTV) is shown in red line.
HA indicates hybrid arc; VMAT, volumetric-modulated arc therapy.
Figure 2. Conformity index of HA and VMAT plans. HA indicates
hybrid arc; VMAT, volumetric-modulated arc therapy.
Figure 3. Gradient index of HA and VMAT plans. HA indicates
hybrid arc; VMAT, volumetric-modulated arc therapy.
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the 13 patients. Optic chiasmmaximum doses are 53.86+ 1.28
Gy (range: 50.44-55.05 Gy) and 53.95 + 1.81 Gy (range:
49.93-55.69 Gy), respectively. Figure 7 shows MU efficiencies
of HA and VMAT plans of the 22 patients. The MU efficien-
cies of HA and VMAT plans are 2.57 + 0.25 (range: 2.14-
3.06) MU/cGy and 2.68 + 0.24 (range: 2.12-3.22) MU/cGy,
respectively.
The results show that HA plans have smaller CI (P¼ .4), GI
(P¼ .0001), and HI (P¼ .0001), that is, better dose conformity
on PTV, faster dose falloff outside PTV, and more homoge-
neous dose distribution within PTV. Figure 8 shows CI, GI, and
HI as functions of PTV volume. The differences of the indexes
between HA and VMAT plans do not show PTV-volume
dependence. Comparisons of brainstem maximum doses and
comparisons of optic chiasm maximum doses do not show
significant differences between HA and VMAT plans (P ¼ .1
and P ¼ .4, respectively). Monitor unit efficiency comparisons
show that HA and VMAT plans have similar MU efficiencies
(P ¼ .2).
Discussion
In our experience, dynamic arcs usually generate such a dose
distribution: dose in the center of the target is 20% to 30%
higher than the periphery. Therefore in the HA planning, we
chose 8:2 to 7:3 ratio between dynamic arc portion and IMRT
portion of the HA plan, to let the dynamic arc contribute most
of the dose, while there is still room for the IMRT to optimize
the intensity, so that the dose in the target can be more uniform.
The ratio was selected based on the MLC margin used for the
dynamic arcs: by our experience, if a 0 to 1 mmMLCmargin is
used, the peripheral dose generated by dynamic arcs will be
*70% of the maximum dose, then 7:3 ratio is used; if a
1*2 mm MLC margin is used, the peripheral dose generated
by dynamic arcs will be above 80% of the maximum dose, and
then 8:2 ratio is used. We plan to further investigate the optimal
ratio in HA planning in the future.
Although the statistical analyses show that CI, GI, and HI
favor HA plans, the amounts of the differences of CI, GI, and
HI between HA and VMAT plans are small, which are 0.08+
0.05, 0.65+ 0.46, and 0.02+ 0.01, respectively. Both HA and
VMAT plans are clinical acceptable.
The results show that HA and VMAT plans have similar
dosimetric results. For clinics where both HA and VMATmod-
alities are available, either HA or VMAT can be used for intra-
cranial radiotherapy. In our clinical practice, since the PTV and
Figure 4. Homogeneity index of HA and VMAT plans. HA indicates
hybrid arc; VMAT, volumetric-modulated arc therapy.
Figure 5. Brainstem maximum dose of HA and VMAT plans. HA
indicates hybrid arc; VMAT, volumetric-modulated arc therapy.
Figure 6. Optic chiasm maximum dose of HA and VMAT plans. HA
indicates hybrid arc; VMAT, volumetric-modulated arc therapy.
Figure 7. Monitor unit (MU) efficiency of HA and VMAT plans. HA
indicates hybrid arc; VMAT, volumetric-modulated arc therapy.
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OARs are drawn in iPLAN image (version 4.1), from the
operation perspective, it is easier to generate an HA plan in
iPlanDose TPS. According to our experience, if HA and VMAT
have the same number of arcs, the delivery time of HA plan is
slightly longer than that of VMAT plan because HA has IMRT
beams in addition to arc beams. But the total treatment time of
an HA treatment is similar to that of a VMAT treatment because
the majority of the treatment time is spent on patient setup and
image verification and the difference in beam delivery time
between HA and VMAT plans is minimal. In our study, a HA
plan has 5 to 6 IMRT beams and a VMAT plan has 3 to 4
VMAT beams. We found that the time spent on plan quality
assurance (QA) measurement of a HA plan and a VMAT plan
was similar when we used the same device, such as a ScandiDos
Delta4 phantom (Uppsala, Sweden), for both plan QA.
As HA can be implemented on any linear accelerator
equipped with DCA and IMRT techniques, in clinics where
DCA and IMRT are available but VMAT is not, HA can
be used.
Conclusions
Hybrid arc plans demonstrate slightly better dose conformity and
dose homogeneity, and slightly steeper dose falloff outside PTV.
The differences are however clinically insignificant. Brainstem
maximum doses and optic chiasm maximum doses are similar
between HA and VMAT plans. Hybrid arc and VMAT plans,
which have similar MU efficiencies, present similar dosimetric
results in the fractionated intracranial radiotherapy.
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